Peter H Goff
5PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 14, 2024
Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses.Thomas Pulliam, Saumya Jani, Peter H Goff
|Jul 25, 2024
Merkel cell carcinoma refractory to anti-PD(L)1: utility of adding ipilimumab for salvage therapy.Tomoko Akaike, Austin J Jabbour, Peter H Goff
|Feb 04, 2022
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells.Peter H Goff, Laura Riolobos, Bonnie J LaFleur
|Jul 24, 2021
Intersection of Two Checkpoints: Could Inhibiting the DNA Damage Response Checkpoint Rescue Immune Checkpoint-Refractory Cancer?Peter H Goff, Rashmi Bhakuni, Thomas Pulliam
|Jul 21, 2017
Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.Peter H Goff, Tomoko Hayashi, Wenqian He
Pageof 1
Frequent Collaborators
3 joint publications
Paul Nghiem
2 joint publications
Kimberly Smythe
2 joint publications
Shailender Bhatia
1 joint publications
Florian Krammer
1 joint publications
Rashmi Bhakuni
1 joint publications
Laura Riolobos
1 joint publications
Bonnie J LaFleur
1 joint publications
Matthew B Spraker
1 joint publications
Y David Seo
1 joint publications
Jean S Campbell
